A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Inclusion Body Myositis
Interventions
DRUG

ABC008

Given by subcutaneous injection

Trial Locations (45)

2065

Royal North Shore Hospital, Saint Leonards

4006

Royal Brisbane and Women's Hospital, Herston

6009

Perron Institute for Neurological and Translational Science, Nedlands

9000

AZ Sint-Lucas & Volkskliniek, Ghent

10021

Hospital for Special Surgery, New York

10032

Columbia University Medical Center / The Neurological Institute of New York, New York

15213

UPMC Arthritis and Autoimmunity Center, Falk Clinic, Pittsburgh

15562

Krankenhaus und Poliklinik Rüdersdorf GmbH, Berlin

17033

Penn State Health Milton S. Hershey Medical Center, Hershey

19104

University of Pennsylvania, Philadelphia

21224

Johns Hopkins Bayview Medical Center, Baltimore

21287

Johns Hopkins University School of Medicine, Baltimore

23233

Virginia Commonwealth University, Henrico

27157

Wake Forrest School of Medicine, Winston-Salem

27710

Duke Neurological Disorders Clinic -1L, Durham

32224

Mayo Clinic, Jacksonville

40225

University Hosptial Duesseldorf, Düsseldorf

43210

The Ohio State University Wexner Medical Center, Columbus

44106

University Hospitals Cleveland Medical Center, Cleveland

53226

Medical College of Wisconsin, Milwaukee

55905

Mayo Clinic, Rochester

60611

Northwestern Memorial Hospital, Department of Neurology (Clinic), Chicago

63110

Washington University School of Medicine, St Louis

66160

University of Kansas Medical, Kansas City

75013

Hospital Pitie-Salpetriere - AP-HP, Paris

75206

Texas Neurology, Dallas

77030

Nerve and Muscle Center of Texas, Houston

78759

Austin Neuromuscular Center, Austin

80045

University of Colorado Hospital Anschutz Outpatient Pavillion, Aurora

85028

Neuromuscular Research Center, Phoenix

90033

Keck Hosptial of USC, Los Angeles

90095

UCLA Medical Center, Los Angeles

92868

University of California Irvine Medical Center (UCIMC) - Amyotrophic Lateral Sclerosis (ALS) and Neuromuscular Center, Irvine

94143

University of California, San Francisco, San Francisco

94304

Stanford Neuroscience Medical Center, Palo Alto

97239

Oregon Health & Science University, Portland

98195

University of Washington Medical Center - Montlake, Seattle

98198

University of Nebraska Medical Center, Omaha

06519

Yale School of Medicine, New Haven

02114

Neuromuscular Diagnostic Center - Massachusetts General Hospital, Boston

021158

Brigham and Womens Hospital, Boston

3M 1M4

Heritage Medical Research Clinic - University of Calgary, Calgary

H4A 3T2

Genge Partners Inc., Montreal

WC1N 3BG

University College London Hospitals NHS Foundation Trust, National Hospital for Neurology and Neurosurgery (NHNN), London

M6 8HD

Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Abcuro, Inc.

INDUSTRY